Previous close | 18.51 |
Open | 18.42 |
Bid | 18.02 x 1300 |
Ask | 19.25 x 800 |
Day's range | 17.93 - 18.50 |
52-week range | 17.73 - 83.60 |
Volume | |
Avg. volume | 472,467 |
Market cap | 198.186M |
Beta (5Y monthly) | 1.16 |
PE ratio (TTM) | 6.76 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 6.60 (35.66%) |
Ex-dividend date | 18 Sept 2023 |
1y target est | N/A |
BALTIMORE, August 05, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024.
BALTIMORE, July 22, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2024 on Monday, August 5, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
BALTIMORE, June 17, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today announced that it has been recognized in the 2024-2025 rankings by U.S. News & World Report as one of the nation’s "Best Companies to Work For" in the food and drink industry. This recognition marks Medifast’s second straight year of inclusion on the list and underscores the company’s ongoing commitment to creating an outstanding workplace